<h1>India Seeks Collaboration with East Asia on Generic Drugs, Vaccines; Supports TRIPS Waiver for Equitable COVID-19 Access.</h1> India is open to collaborating with East Asian nations in producing generic drugs, medical technologies, and vaccines for COVID-19 treatment. At the East Asia Summit-Economic Ministers Meeting, India emphasized the need for a global and equitable vaccine rollout to ensure a strong economic recovery. India supports the TRIPS Waiver proposal and advocates for transparent and reliable supply chains. Despite challenges, India has administered over 740 million vaccine doses and remains committed to fair trade practices. India also seeks to strengthen ties with ASEAN and supports regional economic resilience and innovation, while addressing data protection and cybersecurity challenges.